<DOC>
	<DOCNO>NCT01420809</DOCNO>
	<brief_summary>This post-marketing surveillance study design collect ass information proper use fondaparinux injection , safety efficacy actual use condition , subject undergo orthopedic surgery lower limb high risk develop venous thromboembolism . ( ARIXTRA® trademark GlaxoSmithKline group company . )</brief_summary>
	<brief_title>Special Drug Use Investigation ARIXTRA® ( Fondaparinux ) Injection</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Subjects undergo orthopedic surgery lower limb high risk develop venous thromboembolism</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>